chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10/28/2021 Patient came through our vaccine drive through clinic and received the Moderna Vaccine booster. Upon interview he denied any problems with first two vaccinations and denied any problems with medications, vaccines etc. After lunch his family contacted us stating that "he was having tingling sensation from head to toe" and reported him being so weak he couldn't stand. We contacted him back immediately upon receiving message and he informed the nurse he was speaking to that he hadn't eaten anything that day and was at restaurant when he began to feel poorly. Nurse encouraged him to contact his primary medical doctor if he continued to feel poorly and go to the ER if symptoms worsened. Later that afternoon, nurse checked back with him and he stated that he was feeling better just tired but continued to reports numbness and tingling present just lessened from earlier in the day.   10/29/2021: I called him this morning to check on how he was feeling; he reported that he was feeling better but still weak and continued to state he had some tingling sensation in his extremities. After talking with him for some time he informed me he had received a nerve block earlier in the week at the Center he admitted that he failed to mention that upon interview. I continued to encourage him to call his doctor as well as surgeon at the Center and go to the ER if he started feeling worse or symptoms didn't improve.   11/1/2021: Attempted to contact patient via phone, patient did not answer; went to voicemail
Patient called 10/13/2016 stating the PNEUMOVAX 23 injection site was bright red (like a sunburn), swollen and painful and that she was not feeling well overall.  I called her primary care doctor and spoke to the nurse who then contacted the patient and called me back.  The doctor advised the patient to place ice on the injection site a few times per day and take OTC ibuprofen (2 tablets by mouth three times daily for 2 days) and call doctor after that if she is still not feeling well.
Reports pain after anthrax vaccination.  States that pain progressively worsened and area became pruritic, erythematous and swollen over the next 2 days.  Symptomatic treatment provided.
pt recv vax & for the next two days pt exp feeling extremely exhausted, having a runny nose, chills, & fever 102.5;
Redness & swelling at injection site. Mild peeling of skin (superficial) where swelling is most prominent. Warm compress to site.
3-4 day hx of URI s/s; 21APR93 devel fever to 105; seen by MD 21APR w/dx of tonsillitis (3+ erythema) temp @ center 102; returned to ctr w/in 15 min of leaving ctr; pt seizing; t103.7; given IV valium; taken to ER, t105;
I noticed that I had lumps in my right upper arm the size of a navy bean. My arm has also been really sore.  About a week ago I saw my Doctor and she thought that it may just be connective tissue. They ordered an Ultrasound. I had that done on 9/28/2022. The ultrasound results stated that  it may be a vein. I still have the nodules, and soreness in my arm.
red welp with hard knot at injection site (LA) slightly itchy, slight pain Notified mother to give her Tylenol for pain and Benadryl 25mg every 6 hrs.
Patient's mom called, said 1 hour after getting shot patient had severe muscle spasms. Today he feels like " he was in a car accident". He has never had a flu shot before.
At the time of injection I immediately felt a shocking/burning sensation all the way down my arm to my pinky and ring finger.  I was very painful and concerning.  My fingernails felt like they were going to pop off.   I waited a few days and saw the doctor on call.  Nothing was done at that time.  I waited another week trying ibuprofen for pain but had not much relief.  I had dropped several coffe cups and pans of food before I realized that the nerve problem was worsening.  I then saw the doctor and was prescribed neurontin and physical therapy.  I went to physical therapy and stopped after about one month as advised by my therapist d/t further aggravation of the nerve.    I saw the doctor again, he referred me to a Neurologist.  The appointment is AUG 8th 2021.
Initial information received on 24-Aug-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 61 years old female patient who felt skin at the site was hard and 2/3 of the patient's arm is red, while she received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Aug-2018, the patient received a 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U5979AA; expiry date:13-Jun-2022 via intramuscular route in the left arm. On an unspecified date, the patient developed a non-serious the skin at the site was hard (injection site mass), immediately following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. On an unspecified date ¸the patient developed a nn-serious 2/3 of the patient's arm is red (localised erythema) one-week following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. No lab test reported. Final diagnosis was 2/3 of the patients arm is red and the skin at the site was hard. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Recovered / Resolved on an unknown date for the skin at the site was hard and as Unknown for 2/3 of the patient's arm is red.
Dose 1: aches; fatigue; chills within 24 hours. Swollen arm and tenderness 8 days after first dose. Dose 2: fever; fatigue; aches within 24 hours and lasting for 24 hours.
Information has been received from a physician concerning a female patient who, on an unspecified date, was vaccinated with a 0.5 mL dose of GARDASIL (route and lot number not reported). Physician said the patient experienced chest pain after receiving GARDASIL injection. She went to her primary doctor and had many tests but "everything was fine". It was unknown which dose of the vaccine she received. Subsequently, on an unknown date, the patient recovered from the event. Additional information has been requested.
Arm at administration site swollen and red Hot to touch. Itching with swelling. Took Benadryl - some help took another Swelling & itch went away Red color remained - turned in to "moonshape" 2 days later Benadryl worked immediately, but needed 2 doses
No inflammation at injection site.  Tingling in the arm and fingers IM injection. Within 15 minutes of injection, shortness of breath and tightness of chest, bloating of lateral area. Treatment x 1 epipen with patient laing down with head elevated. Immediately upon administration all symptoms resolved.
angina attack, difficulty breathing and uncontrolled muscle spasms treated and controlled with nitroclycerin, left side of body went numb, difficulty walking, disorientation/dizziness, blurred vision, severe headache, severe muscle and joint pain, weakness.
Information has been received from a registered nurse for GARDASIL, a Pregnancy Registry product, concerning a 22 year old female patient who on 13-JAN-2012, was vaccinated with a dose of GARDASIL (dose, route, lot number not reported). Secondary therapy included MMR II (dose, route, lot number not reported). The patient received MMR II and GARDASIL on 13-JAN-2012, and then discovered she was pregnant. The patient's last menstrual period was on 08-DEC-2011. Estimated delivery date would be 13-SEP-2012. On an unknown date, in 2012, an ultrasound was performed and the patient was diagnosed to have partial placenta previa. The registered nurse stated that the partial placenta previa was probably not due to the vaccinations. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow-up information has been received from a registered nurse via initial pregnancy questionnaire for GARDASIL, a Pregnancy Registry product, concerning a 23 year old female patient with history of anemia and no history of previous pregnancies, full term deliveries, pre-term deliveries, spontaneous abortions, elective terminations, fetal deaths and no obstetric history of birth defects or infant complications in previous pregnancies, who on 13-JAN-2012, was vaccinated with a first dose of GARDASIL (lot number 670049/1171AA) (dose, route not reported). Secondary therapy included MMR II, 0.5 ml (lot number 671483/1008AA) (route not reported). Concomitant therapy included vitamins (unspecified) (one dose daily, used for pregnancy). On 16-MAR-2012, an ultrasound was performed and showed 14 weeks 6 days and the patient was diagnosed to have partial placenta previa. According to ultrasound, estimated delivery date would be 08-SEP-2012. Follow up information had been received from a pediatrician for GARDASIL, a Pregnancy Registry product, reporting that the 23 year old female patient with no concurrent medical conditions, on 08-SEP-2012, 40 weeks from the last menstrual period (LMP), delivered a male infant. The infant's APGAR scores were 8 at one minute and 9 at five minutes. Upon delivery, the infant was noted to be a normal, healthy newborn, with no congenital anomalies and no other complications or abnormalities. It was reported that there were no complications during pregnancy, no complication during delivery, no infections or illness during pregnancy and that on 23-APR-2012 and 14-AUG-2012, an ultrasound was performed which was normal. Additional information is not expected.
I received my dose of the Bivalent Moderna booster on 9/12/2022. On the afternoon of 10/04/2022, I began to get a scratchy throat. At first, I didn't think much of it. As the evening progressed, though, I felt sure that I was coming down with something. When I went to bed that night, I had difficulty sleeping, because I was uncomfortable and beginning to feel achy. On the morning of 10/05/2022, I felt pretty sure I had something. I took the home test for COVID-19 and immediately got a positive result. I spoke to my doctor by telehealth about treatment options. Since I'm on PLAVIX, PAXLOVID wasn't an option. I also opted not to get monoclonal antibodies. I had body aches, fever, upper respiratory congestion, and a headache 10/5/2022-10/7/2022. I took TYLENOL and NYQUIL, which helped with the fever, headaches, and inability to sleep. On 10/8/2022, I had a fever that reached 102.6, and it lasted only about an hour. Afterwards, it began to gradually taper off. Aside from the fever, nasal congestion, and fatigue, all of the other symptoms were gone at this point. On 10/9/2022 and 10/10/2022, I was very fatigued and felt like I had the remnants of a cold. At the time of this writing, I still feel tired, but the fatigue has lessened. Today I was able to work out to a tai chi video. I also still have a little bit of the nasal congestion remaining.
Swollen arm leading to swollen face (per son looks like "the elephant man"). Dr. prescribed Prednisone 50 mg once daily for 5 days.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unkonwn age and gender. Nurse reported that an unspecified number of doses of RECOMBIVAX HB (single dose) (dose, route and lot number were not reported) were administered to patients on unspecified dates after a supported excursion of 20C over a period of 15 hours. No adverse events were reported. This case is linked to cases 1403USA001475, 1403USA002926, 1403USA002927 and 1403USA002929 via same reporter link. Additional information has been requested.
INAPPROPRIATE DOSE OF VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 65 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. the patient was not pregnant at the time of vaccination.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, expiry: 28-JUL-2021) dose was not reported, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-JUL-2021, the subject experienced inappropriate dose of vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of inappropriate dose of vaccine administered was not reported. This report was non-serious.
Patient stated she felt a tingling sensation immediately following administration that lasted for ~15 minutes. The next morning around 4am she woke up with a migraine headache that did not begin to fade until ~5pm and did not go away for ~24 hours. On Friday (48 hours after immunization) she began experiencing a tingling sensation in index finger and the tip of her finger would go numb. This would last about 2-3 minutes then go away. She said she is having this intermittently every 20 minutes depending on activity.
body aches; fatigue; Fever up to 101; cold chills; This is a spontaneous report from a contactable consumer (reported for himself). A 59-year-old male patient received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EM9810), dose 2 via an unspecified route of administration, administered in arm left on 03Feb2021 (at the age of 59-year-old) as dose 2, single for covid-19 immunisation at Hospital. Medical history included enlarged prostate elevated psa ongoing since 1990, hypertension ongoing since 2001, diabetes mellitus ongoing since 2019, blood cholesterol increased ongoing since 2019, prostatomegaly ongoing since 2019, cardiovascular disorder, arthropathy, immune system disorder, cardiac disorder and product communication issue. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. Concomitant medications included rosuvastatin tablets, metformin tablets, hydrochlorothiazide tablet, vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) capsule ongoing since an unknown date for health, amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL) capsule, curcuma longa (TURMERIC) ongoing since an unknown date for cardiovascular disorder, arthropathy, immune system disorder, fish oil (FISH OIL) ongoing since an unknown date for cardiac disorder and serenoa repens (SAW PALMETO) ongoing since an unknown date for prostatomegaly. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EL3249), dose 1 via an unspecified route of administration, administered in arm left on 13Jan2021 at 13:30 (at the age of 59-years-old) as dose 1, single for covid-19 immunisation at Hospital. On 04Feb2021 at 14:00, the patient experienced fever up to 101, cold chills, fatigue and at 14:30 body aches. No treatment was given for the events. The patient underwent lab tests and procedures which included covid-19: negative on 20Nov2020 and body temperature: up to 101 on 04Feb2021. The outcome of the event body aches was resolving, and remaining events were resolved on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 13May2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 27Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 40 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (25Jul2022) Positive, notes: Tested positive; (31Jul2022) Negative; (03Aug2022) Positive, notes: Positive again. Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Nausea, sweating, fatigue, muscle weakness, face numbness (mostly lips & chin), cramps in legs moving from distal to proximal, lightheadedness, palpitations (could feel my heart beat through my teeth), pain in center of palm and center bottom of foot.
Patient reported left sided pruritis and rash on arm and leg, with absence of pain or vesicles. Unknown back involvement.
I rarely, if ever, had headaches and balance issues. After the vaccination I started to have constant minor headaches and minor balance issues. Headaches affect temples and forehead. Balance issues happen when I stand or turn my head. Even when driving the little events on either side of my can cause distraction and make me mildly and briefly disorientated.
Redness at vaccine site, swelling as day went on, bruising, severe swelling and warmth at site.  Eventually about 4-5" in diameter, hard to the touch, painful and warm.  Muscle aches, nausea, slight fever.
Breakthrough case admission after two vaccines Pfizer 3/31/21 Lot# ER8733;  Pfizer 4/21/21  EW0164
Information has been received on 9/22/02 from a health care professional concerning a 17 year old male pt who was vaccinated with first dose of Td (lot U0343AA) IM in the left deltoid and second dose of hep A IM in the right deltoid and hep B (lot 701A2) on 6/27/02 at 8:45. It was reported that 5-7 minutes after the vaccination pt became faint. He progressed to shock and being in and out of consciousness. His color was dusky and ashen. He was also diaphoretic. His blood pressure was 70/30 pulses were weak and thready. Paramedics arrived and transported pt to the hospital. Pt recovered. See case U20020078 and U200200769, same reporter. From additional info received on 9/29/03 from a telephone conversation with the reporter, the telephone and fax numbers for the responsible physician were provided. The reporter stated that "the original info on the VAERs, other than the physician bio, was all they have regarding each individual adverse event case." The adverse event coding was updated. No further info is anticipated, this case is considered closed.
Patient is a 17 yr old F with h/o underimmunizaition presented  for well visit. Revaccination plan continued as previously recommended. Patient did have vasovagal syncopal episode after HPV administration; LOC for <15s with generalized shaking associated with mild diaphoresis ;no foaming or incontinence to suggest seizure. Patient layed supine for rest, Water and food given subsequently given; She tolerated PO without difficulty. Pre and post BP stable. Parent reassured
Right ankle stiffness, progressed to knee stiffness, in April of 2010 diagnosed as ALS.  No known treatment.
Patient passed out after receiving vaccine within about 5 minutes, face became pale and then became pink again, blood pressure dropped and came back up again, last blood pressure reading was low. Patient was in and out but was responsive when EMT arrived. The symptoms took place over a course of about 15 minutes.
Patient stated she felt nauseated and wanted a drink of water, patient was standing by the sink sipping water and started to feel faint, patient was sat on a chair, patient said she felt dizzy, patient knew her name, age, date of birth and where she was, patient lost consciousness and help was called. Dr assisted with patient and took vital signs, patient aroused awake and was moved to exam table where further vitals continued, fluids by mouth and snacks were consumed by patient.
Awakened by pain in left arm, arm bright red, hot to touch and painful. The Shingles vaccine (Zostavax) was administered to my left arm near my tricep on Thursday evening at approximately 5PM by a pharamacist.
Patient describes a reddened, warm to touch, edematous band around left upper arm 1 day after receiving flu vaccine. Seen by MD - diagnosed with cellulitis and started on Keflex BID for 7 days.
Flu-like symptoms (1st dose); body aches (1st dose); Fever (1st dose); Bad headache (1st dose); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms (1st dose)), MYALGIA (body aches (1st dose)), PYREXIA (Fever (1st dose)) and HEADACHE (Bad headache (1st dose)) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms (1st dose)), MYALGIA (body aches (1st dose)), PYREXIA (Fever (1st dose)) and HEADACHE (Bad headache (1st dose)). On 16-Feb-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms (1st dose)), MYALGIA (body aches (1st dose)), PYREXIA (Fever (1st dose)) and HEADACHE (Bad headache (1st dose)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-307462 (Patient Link).
The day after I vomited more than 8 times; The pain got to the point where I had to make 2 different ER visits; I had vision loss and the pain was extreme; Nausea and migraine onset 4 hours after receiving vaccine.; migraine headache; This is a spontaneous report from a contactable consumer (patient himself). A 19-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration, administered in Arm Left, at age 19 years, on 02Sep2021 12:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. Relevant medical history includes COVID-19 prior to vaccination. Patient had no known allergies. The patient had family history of migraine, had no personal history of headaches of any kind before the vaccine, but do have family history of migraines. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. On 02Sep2021 at 16:00, patient had nausea and migraine onset 4 hours after receiving vaccine. The day after, on 03Sep2021, patient vomited more than 8 times and nausea and vomiting continued for 3 days after receiving the vaccine. The migraine headache that occurred lasted for 17 days. The pain got to the point where patient had to make 2 different ER visits as patient had vision loss and the pain was extreme. Patient was seen by medical professionals for the headache and was put on medication that helped for a short amount of time, but the headaches have persisted nearly every day for the past 6 weeks, getting to a point that the pain is the worst pain he ever felt. Treatment for the other events was unknown. He had no personal history of headaches of any kind before the vaccine, but do have family history of migraines. Adverse events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Patient recovered with lasting effects. COVID-19 was not tested post vaccination. The outcome of the event nausea and vomiting was recovered/resolved with sequel on 05Sep2021; while for the other events, it was recovered/resolved with sequel on an unspecified date in 2021.   The lot number for BNT162B2, was not provided and will be requested during follow up.
Day after vaccination, patient experienced fever and muscle soreness. Several days after vaccination, patient experienced painful and itchy rash over left arm and onto left chest. Contacted pharmacy. Was told reaction was normal. Rash worsened, resembled poison ivy. lasted for 4-5 more days. Again told by pharmacy reaction was normal. Patient very miserable. Used ice packs for any relief. More than a week after vaccination, rash remains but pain and itchiness are lessened.